1. Home
  2. PERI vs LXEO Comparison

PERI vs LXEO Comparison

Compare PERI & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perion Network Ltd.

PERI

Perion Network Ltd.

HOLD

Current Price

$9.82

Market Cap

412.5M

Sector

Technology

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$5.74

Market Cap

418.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PERI
LXEO
Founded
1999
2017
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
412.5M
418.9M
IPO Year
2005
2023

Fundamental Metrics

Financial Performance
Metric
PERI
LXEO
Price
$9.82
$5.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$14.50
$18.44
AVG Volume (30 Days)
432.7K
855.6K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.81
EPS
N/A
N/A
Revenue
N/A
$654,000.00
Revenue This Year
$9.95
N/A
Revenue Next Year
$1.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.00
$1.45
52 Week High
$11.44
$10.99

Technical Indicators

Market Signals
Indicator
PERI
LXEO
Relative Strength Index (RSI) 61.03 40.72
Support Level $9.14 $4.93
Resistance Level $10.25 $6.08
Average True Range (ATR) 0.41 0.43
MACD 0.05 0.01
Stochastic Oscillator 65.99 37.77

Price Performance

Historical Comparison
PERI
LXEO

About PERI Perion Network Ltd.

Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Share on Social Networks: